Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Search Results

Title:
A Phase II Study of Hypofractionated Stereotactic Radiotherapy in the Treatment of Metastatic Pediatric Sarcomas of Bony Sites
Protocol Number:
J1367
Phase:
Phase II
Physician:
Stephanie Terezakis
Purpose:
This research is being done to learn if stereotactic body radiation (SBRT) can effectively treat pediatric sarcomas that have spread to the bone and cannot be removed with surgery. Stereotactic radiation is a very focused and precise type of radiation. A higher dose of radiation is given at every treatment over a fewer number of days than standard radiation treatment. Standard radiation delivers less dose of radiation every day over a longer period of time and is delivered with a different technique that generally treats a larger area in the body. We know that stereotactic radiation can stop sarcomas from growing in adults. This study is being performed to learn if this type of radiation can also stop pediatric sarcomas from growing. With stereotactic radiation, we hope to increase the radiation dose to the tumor and decrease the amount of area treated with radiation.
Eligibility:
- People with pediatric sarcoma that has spread to the bone may join - Patients must be greater than 3 years of age and less than or equal to 40 years of age
Treatment:
All patients will recieve 5 doses of radiation over a 5-day period. Patients will then be followed for 3 years.
Population:
Both
Last Update
11/28/2014 04:03 AM
 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

 

Cancer Dictionary

NCI Dictionary of Cancer Terms, a resource with more than 6,000 terms related to cancer and medicine.

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-5222
U.S. 410-955-5222
International +1-410-614-6424

NCI CCC

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.